Andrey Shubin

Dr. Andrey Shubin


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
ASAndrey Shubin
Andrey Shubin
Ilya DemidyukIlya Demidyuk
Ilya Demidyuk
AKAlexey A. Komissarov
Alexey A. Komissarov
LRLola M. Rafieva
Lola M. Rafieva
SKSergey V. Kostrov
Sergey V. Kostrov
Cytoplasmic vacuolization in cell death and survival

Verified
Journal Article
Open access
PDF file
AKAlexey A. Komissarov
Alexey A. Komissarov
MKMaria A. Karaseva
Maria A. Karaseva
MRMarina P. Roschina
Marina P. Roschina
ASAndrey Shubin
Andrey Shubin
NLNataliya A. Lunina
Nataliya A. Lunina
Ilya DemidyukIlya Demidyuk
Ilya Demidyuk
Regulated cell death (RCD) is a fundamental process common to nearly all living beings and essential for the development and tissue homeostasis in animals and humans. A wide range of molecules can induce RCD, including a number of viral proteolytic enzymes. To date, numerous data indicate that picornaviral 3C proteases can induce RCD. In most reported cases, these proteases induce classical caspase-dependent apoptosis. In contrast, the human hepatitis A virus 3C protease (3Cpro) has recently been shown to cause caspase-independent cell death accompanied by previously undescribed features. Here, we expressed 3Cpro in HEK293, HeLa, and A549 human cell lines to characterize 3Cpro-induced cell death morphologically and biochemically using flow cytometry and fluorescence microscopy. We found that dead cells demonstrated necrosis-like morphological changes including permeabilization of the plasma membrane, loss of mitochondrial potential, as well as mitochondria and nuclei swelling. Additionally, we showed that 3Cpro-induced cell death was efficiently blocked by ferroptosis inhibitors and was accompanied by intense lipid peroxidation. Taken together, these results indicate that 3Cpro induces ferroptosis upon its individual expression in human cells. This is the first demonstration that a proteolytic enzyme can induce ferroptosis, the recently discovered and actively studied type of RCD.